Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Paediatric Cardiac Surgery
NCT01562574Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2002
- Primary completion
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor VIIa in acquired bleeding disorder, sponsored by Novo Nordisk. Started Jan 2002; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
acquired bleeding disorder
Beyond the preview
Go deeper on NCT01562574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01562574.